# US 2021/0330731 A1 · Topical salve formulations for dermal alkaloid delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330731 A1
- Document ID: US20210330731A1
- Status: Published application
- Kind: A1
- Application number: 17/242,129
- Filed: 2021-04-27
- Published: 2021-10-28
- Earliest claimed: 2020-04-27
- Inventors: Robert L Martin
- Web page: https://patentgrep.com/patent/US20210330731A1

## CPC

- A61K 36/74: Rubiaceae (Madder family)
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/107: Emulsions {; Emulsion preconcentrates; Micelles (composition of emulsions A61K47/00)}
- A61K 31/05: Phenols {(cannabinoids A61K31/658)}
- A61K 31/20: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K 31/353: 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K 31/4375: the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/23: Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K 36/24: Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
- A61K 36/28: Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K 36/38: Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
- A61K 36/54: Lauraceae (Laurel family), e.g. cinnamon or sassafras
- A61K 36/575: Magnolia
- A61K 36/66: Papaveraceae (Poppy family), e.g. bloodroot
- A61K 36/71: Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K 36/899: Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/51: Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
- A61K 2236/53: Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Various formulations of an alkaloid-containing topical analgesic involve extracting alkaloids from herbal material, infusing a carrier oil, and applying secondary ingredients to improve the formulation's therapeutic efficacy. Suitable herbal sources include, but are not limited to, Mitragyna speciosa, Rauwolfia serpentina, Sceletium tortuosum, Harpagophytum procumbens, Picralima natilda, Sceletium tortuosum, Combretum quadrangulare, Corydalis yanhusuo, Lactuca virosa, and/or Magnolia officinalis. Preferably, alcohol extractions of pre-frozen herbal material were vacuum reduced and the resulting alkaloid extraction was infused into an oil and combined with secondary ingredients, such as alkaloid potentiators, dermal absorption enhancers, anti-inflammation agents, brightening agents, neuropathic pain relief agents, and spasm relief agents.

## Claims

### Claim 1

A method of formulating a topical analgesic, comprising:
producing one or more alkaloid extractions, comprising:
suspending pre-frozen alkaloid-containing herbal material in a cooled alcohol solution for a minimum period of time while applying ultrasonic homogenization to produce an alkaloid extraction;
straining the pre-frozen alkaloid-containing herbal material;
vacuum-reducing the alkaloid extraction(s) to produce a reduced alkaloid syrup;
infusing a carrier oil with the reduced alkaloid syrup to produce alkaloid-infused oil;
combining the alkaloid-infused oil with one or more secondary ingredients selected from the group consisting of: alkaloid potentiators, dermal absorption enhancers, anti-inflammation agents, brightening agents, neuropathic pain relief agents, and spasm relief agents;
hardening the alkaloid-infused oil with a hardening agent; and
emulsifying the alkaloid-infused oil to produce an alkaloid-containing topical analgesic.

### Claim 2 (depends on 1)

The method of claim 1, wherein the herbal material comprises herbal matter selected from the group consisting of: Mitragyna speciosa, Rauwolfia serpentina, Sceletium tortuosum, Harpagophytum procumbens, Picralima natilda, Sceletium tortuosum, Combretum quadrangulare, Corydalis yanhusuo, Lactuca virosa, and/or Magnolia officinalis.

### Claim 3 (depends on 1)

The method of claim 1, wherein the dermal absorption enhancers comprise turmeric oil, black pepper oil, peppermint oil, eucalyptus oil, naioli oil, lemon oil, and sunflower lecithin.

### Claim 4 (depends on 1)

The method of claim 1, wherein the alkaloid potentiatiors comprise trans-resveratrol, berberine, and lemongrass oil.

### Claim 5 (depends on 1)

The method of claim 1, wherein the neuropathic pain relief agents comprise St. John's wort.

### Claim 6 (depends on 1)

The method of claim 1, wherein the anti-inflammation agents comprise arnica oil, cinnamon oil, ginger oil, parsley oil, black seed oil, Ylang Ylang essential oil, and quercetin.

### Claim 7 (depends on 1)

The method of claim 1, wherein the spasm relief agents comprise magnesium stearate.

### Claim 8 (depends on 1)

The method of claim 1, wherein suspending pre-frozen herbal matter in a cooled alcohol solution additionally comprises placing a container containing the pre-frozen herbal matter and the cooled alcohol solution in an ice water bath.

### Claim 9 (depends on 1)

The method of claim 1, wherein suspending pre-frozen herbal matter in a cooled alcohol solution additionally comprises adding citric acid to improve alkaloid extraction.

### Claim 10 (depends on 1)

The method of claim 1, wherein straining the pre-frozen herbal matter involves straining at least once with a plurality of filters of decreasing micron size, from approximately 400 microns to approximately 200 microns.

### Claim 11

A concentrated topical analgesic formulation, comprising:
an alkaloid extraction from pre-frozen alkaloid-containing herbal matter;
wherein the alkaloid extraction is vacuum reduced post extraction;
a carrier oil capable of solubilizing the alkaloid extraction;
a firming agent; and
one or more secondary ingredients selected from the group consisting of: alkaloid potentiators, dermal absorption enhancers, anti-inflammation agents, brightening agents, neuropathic pain relief agents, and spasm relief agents.

### Claim 12 (depends on 11)

The formulation of claim 11, wherein the herbal matter comprises herbal matter selected from the group consisting of: Mitragyna speciosa, Rauwolfia serpentina, Sceletium tortuosum, Harpagophytum procumbens, Picralima natilda, Sceletium tortuosum, Combretum quadrangulare, Corydalis yanhusuo, Lactuca virosa, and/or Magnolia officinalis.

### Claim 13 (depends on 11)

The formulation of claim 11, wherein the dermal absorption enhancers comprise turmeric oil, black pepper oil, peppermint oil, eucalyptus oil, naioli oil, lemon oil, and sunflower lecithin.

### Claim 14 (depends on 11)

The formulation of claim 11, wherein the alkaloid potentiatiors comprise trans-resveratrol, berberine, and lemongrass oil.

### Claim 15 (depends on 11)

The formulation of claim 11, wherein the neuropathic pain relief agents comprise St. John's wort.

### Claim 16 (depends on 11)

The formulation of claim 11, wherein the anti-inflammation agents comprise arnica oil, cinnamon oil, ginger oil, parsley oil, black seed oil, Ylang Ylang essential oil, and quercetin.

### Claim 17 (depends on 1)

The formulation of claim 1, wherein the spasm relief agents comprise magnesium stearate.
